To investigate the metabolic effect of the drug, in this study AML cells were treated with 1 mM of ascorbate, which significantly inhibited the expression levels of Hexokinase II (HK2), a main glycolysis-initiating enzyme in the hemopoietic system (Figure 3b) and in tumors [28]. This evidence concerns the gene HK2 and acute myeloid leukemia.